电话:022-23006807

公司简介

天津药物研究院有限公司(Tianjin Institute of Pharmaceutical Research Co., Ltd.)(以下简称药研院)始建于1959年,是原国家医药管理局直属的全国综合性医药科研单位之一。2000年转制进入天津市国资系统,2018年通过国有企业混合所有制改革,成为招商局集团旗下现代研发型制药企业。

药研院发展至今,建立了“释药技术与药代动力学国家重点实验室”、“中药现代制剂与质量控制技术国家地方联合工程实验室”以及9个天津市重点实验室和工程研究中心。编辑出版《中草药》、《Chinese Herbal Medicines》、《现代药物与临床》、《药物评价研究》四本核心期刊,其中,《中草药》蝉联中药类期刊排名第一,荣获出版政府奖、国家期刊奖、60年最具影响力期刊奖等多项荣誉。拥有一支以中国工程院院士刘昌孝领衔,涵盖药物合成、中药新药、药物制剂、药物分析、药物评价、医药信息等领域的专家团队,其中,包括国家药典委员会委员、国家药品审评专家、国家发改委药品价格审评专家、国务院特贴专家、天津市新药审评专家、天津市“131工程”一层次人才等。与此同时,积极推动我国医药领域高端人才的培养,与10余所高校设立硕士、博士培养点、1个博士后科研工作站,成为全国药学专业研究生培养示范基地。

截至目前,药研院累计完成国家级和省部级重大科研项目200多项,取得科研成果700多项,获得新药证书、临床批件或生产批件300余项,荣获国际、国内各级奖励300多项,拥有授权专利近500项,其中多项获得中国专利优秀奖、天津市专利金奖,为社会奉献了诸如速效救心丸、寿比山、麻仁软胶囊、地佐辛、小儿豉翘清热颗粒等一大批知名好药,成就了20多家上市药企。荣获了全国技术转移示范机构、首批国家知识产权运营试点单位、全国企事业知识产权示范单位、以及科技部、国资委、全国总工会三部委认定的“创新型企业”、“全国医药工业最具投资价值企业”等荣誉称号。

当前,药研院着力打造新药研发、技术服务、生产销售三大核心业务板块,形成药物发现研究、临床前研究、临床研究、产业化上市营销四大配套体系,拥有GMP、GLP、GSP、AAALAC、CNAS等行业准入资质,业务领域和技术优势涵盖了药物研究全学科、产业发展全链条。近年研发的诸如知非沙班、泰格列净、泰宁纳德等多项1.1类新药,已获批进入临床研究。为众多合作伙伴,提供新药评价研究、中药大品种二次开发、一致性评价研究、临床医学管理等各类技术服务。拥有专门从事药物评价研究的服务机构(CRO),汇集药代动力学、药效学和毒理学三大学科优势,具备先进动物模型和技术手段,具有健全的质量管理体系,评价项目均一次性通过审核,多个项目获得美国FDA认可。已建成口服固体制剂、小容量注射剂和原料药生产基地,是国家精神药品定点生产单位,产品领域围绕精神神经、镇痛抗炎、糖尿病治疗、肝病治疗、心脑血管治疗等,形成了覆盖全国及部分国外市场的营销网络。

未来,药研院将以“科技兴药、惠福人类”为使命,以建成“世界有影响力、中国一流的研发型制药企业”为目标,持续加强创新驱动、大力推进产研融合,做强、做优创新药、生物药、中医药、仿制药、功能食品和药物评价六大版图,不断实现企业发展的新跨越和新突破,努力建成百年药研院、世界药研院。


Tianjin Institute of Pharmaceutical Research (TIPR), as one of the nation’s most important institutes, has a history of over half a century and has been engaged in pharmaceutical research and development. Today it has grown from an academic research institute up to a comprehensive high-tech pharmaceutical enterprise integrating scientific research, manufacture and sales. The scientific research of TIPR covers the fields of drug synthesis, pharmaceutical preparations, Chinese medicine pharmacy, modern biological pharmaceutical, pharmacological drug, drug safety evaluation, drug analysis and medical information. With advanced talents and relying on the State Key Laboratory as well as other professional platforms, TIPR pays special attention to the engineering and industrialization of new technology. Meanwhile it meets all kinds of new drug registration requirements. Its technologies in the fields of drug metabolism and pharmacokinetics, safety evaluation and new preparation are in the leading positions in China.

TIPR possesses independent industrial and technical service platforms to promote the transfer of research achievements. We are composed of TIPR Pharmaceutical Co., Ltd.(holding controlled) , TIPR Drug Assessment Co., Ltd. (holding controlled), TIPR-HUYA AIM Co., Ltd. and other pharmaceutical enterprises. For over 50 years, TIPR has carried out fruitful cooperation with pharmaceutical companies all over the country, which not only provides a large number of excellent new medicinal products for the society, but also produces many outstanding enterprises.

With a comprehensive research mechanism and a professional talent team, TIPR has been continuously offering new products and technologies by maintaining close observation of the changes and trends of the pharmaceutical industry. In addition to developing new and excellent pharmaceutical products, TIPR has also brought generous economic returns to our partners. With our comprehensive and professional technical service, TIPR is committed to promoting the upgrading of your products and making your dream come true.




  


骚虎影视,骚虎网站,骚虎影视